Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G van de Wetering
Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From a Dutch Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients From a Swedish Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCV45 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes From a Turkish Health Care Perspective Based on Data From the Plato Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy96 - Cost-Effectiveness of Originator Adalimumab in Non-Infectious Intermediate, Posterior and Pan-Uveitis From a Societal Perspective in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost of Non-Adherence to Medication in a Post-Mi Population
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Assessment of MI Myocardial Infarction Risk Factors Among Post-Mi
International Journal of Trend in Scientific Research and Development
Pcn170 - Cost-Effectiveness of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Canadian Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine for First-Line Treatment of Patients With Metastatic Pancreatic Cancer From the US Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost-Effectiveness of Tavi in Intermediate Risk Patients in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
